Archives: Press Releases

MENLO PARK, Calif., Aug. 5, 2022 /PRNewswire/ — PacBio (NASDAQ: PACB) announced today that it will be participating in the upcoming UBS Genomics 2.0 and MedTech Innovations Summit in Dana…

MENLO PARK, Calif., Aug. 3, 2022 /PRNewswire/ — PacBio (NASDAQ: PACB) today announced financial results for the quarter ended June 30, 2022. Second quarter results Revenue of $35.5 million, a…

MENLO PARK, Calif., July 21, 2022 /PRNewswire/ – PacBio (NASDAQ: PACB), a leading developer of high-quality, highly accurate sequencing solutions, today announced the appointment of Jeff Eidel as Chief Commercial…

MENLO PARK, Calif., July 18, 2022 – PacBio (NASDAQ: PACB) announced today that it will hold its quarterly conference call to discuss its second quarter 2022 financial results on Wednesday,…

MENLO PARK, Calif., June 27, 2022 (GLOBE NEWSWIRE) — PacBio (NASDAQ: PACB), a leading provider of high-quality, highly accurate sequencing platforms, today announced that the Compensation Committee of the Company’s…

Advanced Automation Aims to Optimize Service Lab Efficiency and Highly Reproducible Data Production from HiFi Long-Read Sequencing MENLO PARK, Calif., TOKYO, May 09, 2022 (GLOBE NEWSWIRE) — PacBio (NASDAQ: PACB),…

MENLO PARK, Calif., May 05, 2022 (GLOBE NEWSWIRE) — PacBio announced today that it will be participating in the upcoming BofA Securities 2022 Healthcare Conference in Las Vegas, Nevada. PacBio’s…

MENLO PARK, Calif., May 04, 2022 (GLOBE NEWSWIRE) — PacBio (NASDAQ: PACB) today announced financial results for the quarter ended March 31, 2022. First quarter results Revenue of $33.2 million,…

MENLO PARK, Calif., April 21, 2022 (GLOBE NEWSWIRE) — PacBio (NASDAQ: PACB), a leading provider of high-quality, highly accurate sequencing solutions, today announced an expanded research collaboration with Children’s Mercy Kansas…

Significant Enhancements to the Sequel II/IIe Platform Include Methylation Calling in Native DNA, Greatly Accelerated Sample Preparation, and Support for Gene Therapy Applications MENLO PARK, Calif., April 21, 2022 (GLOBE…

MENLO PARK, Calif., April 20, 2022 (GLOBE NEWSWIRE) — PacBio (NASDAQ: PACB) announced today that it will hold its quarterly conference call to discuss its first quarter 2022 financial results…

The Companies Will Leverage High-Throughput Whole Genome HiFi Sequencing for Advanced Plant Biotechnology, Breeding and Crop Protection Product Development MENLO PARK, Calif., April 04, 2022 (GLOBE NEWSWIRE) — PacBio (NASDAQ:…

Science Magazine Publication Details How the Human Genome was Finally Completed with the Help of PacBio Long-Read Technology MENLO PARK, Calif., March 31, 2022 (GLOBE NEWSWIRE) — PacBio (NASDAQ: PACB),…

Company Announces New European Headquarters to Serve Growing Customer Demand in Europe, Middle East and Africa Region Also Announces First Commercial Services Provider in Europe MENLO PARK, Calif., March 23,…